Lineage Cell Therapeutics, Inc. (LCTX): Shares Outstanding
243.12M
As of 2025-12-31
252.91M
As of 2026-06-30
+12.6%
3-year compound annual growth
+9.7%
5-year compound annual growth
+10.4%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 243.12M | +10.3% | 2026-03-05, Balance as of period end |
| 2024-12-31 | 220.42M | +26.0% | 2026-03-05, Balance as of period end |
| 2023-12-31 | 174.99M | +2.9% | 2025-03-10, Balance as of period end |
| 2022-12-31 | 170.09M | +0.4% | 2024-03-07, Balance as of period end |
| 2021-12-31 | 169.48M | +10.7% | 2023-03-09, Balance as of period end |
| 2020-12-31 | 153.10M | +2.2% | 2022-03-10, Balance as of period end |
| 2019-12-31 | 149.80M | +17.8% | 2021-03-11, Balance as of period end |
| 2018-12-31 | 127.14M | +0.2% | 2020-03-12, Balance as of period end |
| 2017-12-31 | 126.87M | +23.4% | 2019-03-14, Balance as of period end |
| 2016-12-31 | 102.78M | +13.7% | 2018-03-15, Balance as of period end |
| 2015-12-31 | 90.42M | +15.6% | 2017-03-16, Balance as of period end |
| 2014-12-31 | 78.23M | +37.9% | 2016-03-15, Balance as of period end |
| 2013-12-31 | 56.71M | +14.8% | 2015-03-11, Balance as of period end |
| 2012-12-31 | 49.38M | +0.7% | 2014-03-17, Balance as of period end |
| 2011-12-31 | 49.04M | +2.6% | 2013-03-18, Balance as of period end |
| 2010-12-31 | 47.78M | n/a | 2012-03-14, Balance as of period end |